Our previous studies have shown that MYH9 attenuated the GSK3β-mediated ubiquitination and degradation of β-catenin, thereby facilitating Wnt signaling activity and promoting proliferation, metastasis, and chemoresistance of cancer cells [9]. Here, MYH9 is linked to cancer.